<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the role of <z:mp ids='MP_0001845'>inflammation</z:mp> in the phenotypic expression of <z:hpo ids='HP_0001685'>myocardial fibrosis</z:hpo> in <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> (HCM) </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Clinical study </plain></SENT>
<SENT sid="2" pm="."><plain>SETTING: Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland </plain></SENT>
<SENT sid="3" pm="."><plain>SUBJECTS: Twenty-four patients with a single HCM-causing mutation D175N in the α-tropomyosin gene and 17 control subjects </plain></SENT>
<SENT sid="4" pm="."><plain>MAIN OUTCOME MEASURES: Endomyocardial biopsy samples taken from the patients with HCM were compared with matched myocardial autopsy specimens </plain></SENT>
<SENT sid="5" pm="."><plain>Levels of high-sensitivity C-reactive protein (hsCRP) and proinflammatory cytokines were measured in patients and controls </plain></SENT>
<SENT sid="6" pm="."><plain>Myocardial late <z:chebi fb="0" ids="33375">gadolinium</z:chebi> enhancement (LGE) in cardiac MRI (CMRI) was detected </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Endomyocardial samples in patients with HCM showed variable myocyte <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> and size <z:hpo ids='HP_0001425'>heterogeneity</z:hpo>, myofibre disarray, <z:mp ids='MP_0003045'>fibrosis</z:mp>, inflammatory cell infiltration and nuclear factor kappa B (NF-κB) activation </plain></SENT>
<SENT sid="8" pm="."><plain>Levels of hsCRP and interleukins (IL-1β, IL-1RA, IL-6, IL-10) were significantly higher in patients with HCM than in control subjects </plain></SENT>
<SENT sid="9" pm="."><plain>In patients with HCM, there was a significant association between the degree of myocardial inflammatory cell infiltration, <z:mp ids='MP_0003045'>fibrosis</z:mp> in histopathological samples and myocardial LGE in CMRI </plain></SENT>
<SENT sid="10" pm="."><plain>Levels of hsCRP were significantly associated with histopathological <z:hpo ids='HP_0001685'>myocardial fibrosis</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>hsCRP, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor α and IL-1RA levels had significant correlations with LGE in CMRI </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: A variable myocardial and systemic <z:mp ids='MP_0001845'>inflammatory response</z:mp> was demonstrated in patients with HCM attributable to an identified sarcometric mutation </plain></SENT>
<SENT sid="13" pm="."><plain><z:mp ids='MP_0001845'>Inflammatory response</z:mp> was associated with <z:hpo ids='HP_0001685'>myocardial fibrosis</z:hpo>, suggesting that <z:hpo ids='HP_0001685'>myocardial fibrosis</z:hpo> in HCM is an active process modified by an <z:mp ids='MP_0001845'>inflammatory response</z:mp> </plain></SENT>
</text></document>